123 related articles for article (PubMed ID: 38879085)
1. Aurora kinase A is overexpressed in human retinoblastoma and correlates with histopathological high-risk factors: implications for targeted therapy.
Borah NA; Mittal R; Sucharita S; Rath S; Kaliki S; Patnaik S; Tripathy D; Reddy MM
Am J Pathol; 2024 Jun; ():. PubMed ID: 38879085
[TBL] [Abstract][Full Text] [Related]
2. Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma.
Borah NA; Sradhanjali S; Barik MR; Jha A; Tripathy D; Kaliki S; Rath S; Raghav SK; Patnaik S; Mittal R; Reddy MM
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):16. PubMed ID: 33704359
[TBL] [Abstract][Full Text] [Related]
3. The Oncogene
Sradhanjali S; Rout P; Tripathy D; Kaliki S; Rath S; Modak R; Mittal R; Chowdary TK; Reddy MM
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680394
[TBL] [Abstract][Full Text] [Related]
4. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
5. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
Alkatan HM; AlQahtani FS; Maktabi AM
Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
[TBL] [Abstract][Full Text] [Related]
6.
De Rosa P; Severi F; Zadran SK; Russo M; Aloisi S; Rigamonti A; Capranico G; Milazzo G; Perini G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982482
[TBL] [Abstract][Full Text] [Related]
7. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
Mosquera JM; Beltran H; Park K; MacDonald TY; Robinson BD; Tagawa ST; Perner S; Bismar TA; Erbersdobler A; Dhir R; Nelson JB; Nanus DM; Rubin MA
Neoplasia; 2013 Jan; 15(1):1-10. PubMed ID: 23358695
[TBL] [Abstract][Full Text] [Related]
8. Role of MYCN in retinoblastoma: A review of current literature.
Vempuluru VS; Maniar A; Bakal K; Kaliki S
Surv Ophthalmol; 2024 May; ():. PubMed ID: 38796108
[TBL] [Abstract][Full Text] [Related]
9. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
[TBL] [Abstract][Full Text] [Related]
10. Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers.
Ghosh S; Mazumdar T; Xu W; Powell RT; Stephan C; Shen L; Shah PA; Pickering CR; Myers JN; Wang J; Frederick MJ; Johnson FM
Clin Cancer Res; 2022 Oct; 28(20):4479-4493. PubMed ID: 35972731
[TBL] [Abstract][Full Text] [Related]
11. Effect of CDK7 inhibitor on MYCN-amplified retinoblastoma.
Xu H; Xiao L; Chen Y; Liu Y; Zhang Y; Gao Y; Man S; Yan N; Zhang M
Biochim Biophys Acta Gene Regul Mech; 2023 Sep; 1866(3):194964. PubMed ID: 37536559
[TBL] [Abstract][Full Text] [Related]
12. Treatment of RB-deficient retinoblastoma with Aurora-A kinase inhibitor.
Yang W; Jiang XX; Zhao XY; Mao PA
Kaohsiung J Med Sci; 2022 Mar; 38(3):244-252. PubMed ID: 34741392
[TBL] [Abstract][Full Text] [Related]
13. NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.
Ice RJ; McLaughlin SL; Livengood RH; Culp MV; Eddy ER; Ivanov AV; Pugacheva EN
Cancer Res; 2013 May; 73(10):3168-80. PubMed ID: 23539442
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
Korobeynikov V; Borakove M; Feng Y; Wuest WM; Koval AB; Nikonova AS; Serebriiskii I; Chernoff J; Borges VF; Golemis EA; Shagisultanova E
Breast Cancer Res Treat; 2019 Sep; 177(2):369-382. PubMed ID: 31254157
[TBL] [Abstract][Full Text] [Related]
16. Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the
Gong X; Du J; Parsons SH; Merzoug FF; Webster Y; Iversen PW; Chio LC; Van Horn RD; Lin X; Blosser W; Han B; Jin S; Yao S; Bian H; Ficklin C; Fan L; Kapoor A; Antonysamy S; Mc Nulty AM; Froning K; Manglicmot D; Pustilnik A; Weichert K; Wasserman SR; Dowless M; Marugán C; Baquero C; Lallena MJ; Eastman SW; Hui YH; Dieter MZ; Doman T; Chu S; Qian HR; Ye XS; Barda DA; Plowman GD; Reinhard C; Campbell RM; Henry JR; Buchanan SG
Cancer Discov; 2019 Feb; 9(2):248-263. PubMed ID: 30373917
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma with MYCN Amplification Diagnosed from Cell-Free DNA in the Aqueous Humor.
Joseph S; Pike S; Peng CC; Brown B; Xu L; Berry JL; Chévez-Barrios P; Hubbard GB; Grossniklaus HE
Ocul Oncol Pathol; 2024 Apr; 10(1):15-24. PubMed ID: 38751495
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancer.
Burgess EF; Livasy C; Trufan S; Zhu J; O'Connor HF; Hartman A; Clark PE; Grigg C; Raghavan D
Mol Clin Oncol; 2022 May; 16(5):102. PubMed ID: 35463214
[TBL] [Abstract][Full Text] [Related]
20. High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study.
Alkatan HM; Al-Dahmash SA; Almesfer SA; AlQahtani FS; Maktabi AMY
Int Ophthalmol; 2020 Nov; 40(11):2875-2887. PubMed ID: 32632618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
